NCT07803588

Recruiting

A Study to Test the AdaptDx Pro Agreement in Rod Intercept T...

AdaptDx, Inc.Source

Compare

Other study identifiers

Sponsor study identifier

OPZ002

Study Type

observational

Estimated enrollment

24

Locations

1 country

Sites

1

Timeline

Study Start

September 15, 2026

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

January 1, 2027

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Study Completion

March 1, 2027

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Brief Summary

The purpose of this study is to test the AdaptDx Pro agreement in Rod Intercept (RI) time with the AdaptDx tabletop (AdaptDx) in healthy subjects with normal vision.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: recruiting
Estimated enrollment: 24 participants
Study completion date: March 1, 2027
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
August 18, 2026
Actual (reported)
First Posted
September 3, 2026
Actual (reported)
Study Start
September 15, 2026
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
January 1, 2027
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
March 1, 2027
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated: September 3, 2026
Status Verified: September 2026
Last Update Submitted: September 2, 2026

Conditions

Healthy Adult Participants

Keywords

Dark adaptationrod-mediated dark adaptation

Outcome Measures

Primary Outcomes (1)

Rod Intercept Time
the time in minutes it takes for the eye's rod photoreceptors to recover sensitivity after a bright flash of light
Immediately after the dark adaptation test

Study Arms (2)

AdaptDx Tabletop

Rod intercept time will be measured using the AdaptDx Tabletop device

Diagnostic Test: AdaptDx Tabletop vs AdaptDx Pro

AdaptDx Pro Wearable

Rod intercept time will be measured using the AdaptDx Pro device

Diagnostic Test: AdaptDx Tabletop vs AdaptDx Pro

Interventions

AdaptDx Tabletop vs AdaptDx ProDiagnostic test

Two variations of AdaptDx dark adaptation devices.

AdaptDx Pro WearableAdaptDx Tabletop

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age22 Years - 49 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

Healthy adult individuals with no ocular disorder or disease.

You may qualify if:

Subjects enrolled in the study will be required to meet all the following criteria for both eyes:

Sponsors & Collaborators

AdaptDx, Inc.
Industrylead

Study Sites (1)

Retina Consultants San Diego

San Diego, California, 92101, United States

RECRUITING

Nikolas London, MD, FACSCONTACT858-451-1911 london@rcsd.com

Central Study Contacts

Cindy Croissant VP, Clinical Operations, BS, MBA

CONTACT

858 397 1021 ccroissant@opzira.com

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

August 18, 2026

First Posted

September 3, 2026

Study Start

September 15, 2026

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

January 1, 2027

Estimated

NCT07837778

Anchoring and Postural Stability

Not ApplicableRecruiting

NCT07829939

Understanding Oral Nicotine Pouch Use in Healthy Volunteers

Phase 1Not Yet Recruiting

NCT07758777

Usability Evaluation of the Intelligent Fingerprinting Drug Screening System

Not ApplicableCompleted

NCT07884734

A Study to Evaluate the Effect of Carbamazepine or Itraconazole on Radiprodil in Healthy Adult Participants

Phase 1Active Not Recruiting

NCT07775495

Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure

Recruiting

NCT07514741

Safety and Efficacy of a Prebiotic Blend in Healthy Humans

Not ApplicableCompleted

Male or female between the ages of 22 and 49 (inclusive) at Visit 1

ETDRS BCVA letter score of 85 (Snellen equivalent of 20/20) or better at Visit 1

Able to communicate well with the Investigator and able to understand and comply with the requirements of the study

Informed of the nature of this study and has provided written informed consent in accordance with institutional, local and national regulatory guidelines

You may not qualify if:

Unable to follow simple instructions, operate a response button or maintain attention for 20 minutes
Diagnosis or history of any ocular disease or disorder
Serious medical illness that will prevent the subject from performing study activities (including cardiac, hepatic, renal, respiratory, endocrinologic, neurologic, or hematologic disease) or, in the judgement of the Investigator, is likely to require surgical intervention or hospitalization at any point during the study
Presence of or history of malignancy within the past year of Visit 1 other than non-melanoma skin or squamous cell cancer or cervical carcinoma in-situ
Is non-ambulatory
History of drug, alcohol or substance abuse within 3 months prior to Visit 1
Has received an investigational drug or treatment with an investigational device within 3 months prior to Visit 1
In the opinion of the Investigator, is unlikely to comply with the study protocol

Contact the study team to confirm eligibility.

Planned date reported by the registry; this milestone is not confirmed as achieved.

Study Completion

March 1, 2027

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated

September 3, 2026

Record last verified: 2026-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT07803588
Data provider: ClinicalTrials.gov
Source updated: 2026-09-03
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:38:53 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

AdaptDx Tabletop

AdaptDx Pro Wearable

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations